ENRIQUE FLECHAS: Open Payments
NPI 1396801734 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 34 payments from 11 companies in 2025. Trend: 2023 $665 · 2024 $729 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $193 |
| Almatica Pharma LLC | 4 | $94 |
| Sage Therapeutics, LLC | 4 | $77 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Lundbeck LLC | 1 | $25 |
Products named: VRAYLAR, ZURZUVAE, LOREEV XR, FANAPT, REXULTI, AUSTEDO XR, Qelbree, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
